Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001427733-11-000001
Filing Date
2011-10-14
Accepted
2011-10-14 16:14:49
Documents
1
Effectiveness Date
2011-10-14
Items
Item 06: Rule 506

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 8930
  Complete submission text file 0001427733-11-000001.txt   10104
Mailing Address 101 MAIN STREET SUITE 1210 CAMBRIDGE MA 02142
Business Address 101 MAIN STREET SUITE 1210 CAMBRIDGE MA 02142 617-300-8500
Virdante Pharmaceuticals, Inc. (Filer) CIK: 0001427733 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-114968 | Film No.: 111142015